RL66 a second-generation curcumin analog has potent in vivo and in vitro anticancer activity in ER-negative breast cancer models
Babasaheb D. Yadav(University of Otago), Rhonda J. Rosengren(University of Otago)
Cited by 26
Related Papers
A novel curcumin derivative increases the cytotoxicity of raloxifene in estrogen receptor-negative breast cancer cell lines
|International Journal of Oncology|2015|13